Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06556745 · ClinicalTrials.gov registry record

Pharmacokinetics of Butyrate Tablet BKR-017

A clinical trial of Hypercholesterolemia, sponsored by BioKier.

Recruiting
Registry status
10
Enrollment target
1
Study location

NCT06556745 is a study of Hypercholesterolemia that is actively recruiting participants, run by BioKier. The registered enrollment target is 10 participants, below the 817-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06556745, a study of Hypercholesterolemia, is actively recruiting participants, sponsored by BioKier.

RECRUITING
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the pharmacokinetic profile and systemic exposure of BKR-017 in individuals on statin therapy after a single dose and at steady state after seven days repeated twice daily dosing.

Conditions Studied

Interventions

  • DRUG BKR-017

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-07-16
Est. Completion 2025-12-30

Sponsor

BioKier

4 total trials

What the Registry Record Tells You About NCT06556745

The ClinicalTrials.gov registry entry for NCT06556745 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (99% lower). The listed sponsor is BioKier, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypercholesterolemia appearing as the primary indexed condition, and to 1 intervention - of which BKR-017 is the first listed.

NCT06556745 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT06556745 about?

NCT06556745 is a clinical study titled "Pharmacokinetics of Butyrate Tablet BKR-017". The purpose of this study is to evaluate the pharmacokinetic profile and systemic exposure of BKR-017 in individuals on statin therapy after a single dose and at steady state after seven days repeated twice daily dosing.

What is the current status of trial NCT06556745?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-07-16. Estimated completion is 2025-12-30.

What conditions does trial NCT06556745 study?

This clinical trial studies the following conditions: Hypercholesterolemia.

What interventions are being tested in trial NCT06556745?

The interventions under investigation include: BKR-017 (DRUG).

Who is sponsoring clinical trial NCT06556745?

This trial is sponsored by BioKier, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06556745 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypercholesterolemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.